London · Delayed Price · Currency is GBP · Price in GBX Faron Pharmaceuticals Oy Statistics
Total Valuation
AIM:FARN has a market cap or net worth of GBP 77.09 million. The enterprise value is 64.99 million.
| Market Cap | 77.09M |
| Enterprise Value | 64.99M |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:FARN has 202.88 million shares outstanding. The number of shares has increased by 25.62% in one year.
| Current Share Class | 202.88M |
| Shares Outstanding | 202.88M |
| Shares Change (YoY) | +25.62% |
| Shares Change (QoQ) | +31.66% |
| Owned by Insiders (%) | 8.84% |
| Owned by Institutions (%) | 6.42% |
| Float | 155.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.75 |
| P/TBV Ratio | 8.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 1.55.
| Current Ratio | 2.40 |
| Quick Ratio | 2.28 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.89 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.77% |
| Return on Invested Capital (ROIC) | -68.26% |
| Return on Capital Employed (ROCE) | -89.37% |
| Weighted Average Cost of Capital (WACC) | 8.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -390,929 |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:FARN has paid 1,722 in taxes.
| Income Tax | 1,722 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.88% in the last 52 weeks. The beta is 1.12, so AIM:FARN's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -81.88% |
| 50-Day Moving Average | 40.81 |
| 200-Day Moving Average | 81.70 |
| Relative Strength Index (RSI) | 41.27 |
| Average Volume (20 Days) | 55,191 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.76M |
| Pretax Income | -14.07M |
| Net Income | -14.07M |
| EBITDA | -16.55M |
| EBIT | -16.76M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
The company has 27.53 million in cash and 15.43 million in debt, with a net cash position of 12.11 million or 0.06 per share.
| Cash & Cash Equivalents | 27.53M |
| Total Debt | 15.43M |
| Net Cash | 12.11M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 9.95M |
| Book Value Per Share | 0.05 |
| Working Capital | 16.87M |
Cash Flow
| Operating Cash Flow | -17.30M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 202,804 |
| Net Borrowing | 8.23M |
| Free Cash Flow | -17.30M |
| FCF Per Share | -0.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:FARN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.62% |
| Shareholder Yield | -25.62% |
| Earnings Yield | -18.25% |
| FCF Yield | -22.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |